RecruitingNot ApplicableNCT03389542

Early Mitral ValvE Repair Versus Watchful Waiting for Asymptomatic SEvere Degenerative Mitral Regurgitation

Randomized Comparison of Early Mitral ValvE Repair Versus Watchful Waiting for Asymptomatic SEvere Degenerative Mitral Regurgitation Due to Leaflet Prolapse


Sponsor

Centre Hospitalier Universitaire, Amiens

Enrollment

424 participants

Start Date

Apr 10, 2018

Study Type

INTERVENTIONAL

Conditions

Summary

Degenerative mitral regurgitation (MR) due to leaflet prolapse is frequent and can be surgically repaired in the vast majority of patients. Despite the efficacy of mitral valve repair, an ongoing international controversy exists regarding the need to perform early surgery in asymptomatic patients with severe MR and no sign of LV dysfunction in whom the probability of successful and durable repair is very high. In this group of patients, differing views of the risks of uncorrected severe MR exist: considered as benign by those supporting medical "watchful waiting" or associated with significant excess mortality/morbidity by those advocating early surgery. This controversy can only be resolved by a randomized controlled trial which is still lacking. The main objective is to demonstrate the superiority of early mitral valve repair in patients with asymptomatic severe MR due to leaflet prolapse compared to an initial conservative management in terms of all-cause death and cardiovascular morbidity during five years follow-up.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Inclusion Criteria7

  • Asymptomatic patients according history or an exercise test in those able to perform it if there is a doubt about the absence of symptoms
  • Severe (grade IV) degenerative MR due to leaflet prolapse assessed by echocardiography
  • LV ejection fraction by Simpson biplane method ≥60% and LV end-systolic diameter by TM echocardiography ≤40mm
  • Sinus rhythm on the inclusion ECG
  • Pulmonary artery pressure ≤50 mmHg by Doppler echocardiography.
  • High probability of mitral valve repair
  • EuroSCORE II ≤ 3%

Exclusion Criteria8

  • Mitral stenosis or > mild aortic valve disease (stenosis or regurgitation)
  • Congenital heart disease (except patent foramen ovale or atrial septal defect)
  • Patients with cardiac prostheses
  • Previous myocardial infarction
  • Previous cardiac surgery
  • Extra cardiac comorbidity with life expectancy < 5 years
  • Recent history of psychiatric disease (including drug or alcohol abuse)
  • Therapy with an investigational intervention at the time of screening or plan to enrol patient in additional intervention study during participation in this trial

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURESurgery

Early mitral valve repair

OTHERClinical interview and echocardiography

Clinical interview and echocardiography every 6 months.


Locations(2)

CHU Amiens-Picardie

Amiens, France

Centre Cardiologique du Nord

Saint-Denis, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03389542